| UniProt ID | NKD2_HUMAN | |
|---|---|---|
| UniProt AC | Q969F2 | |
| Protein Name | Protein naked cuticle homolog 2 | |
| Gene Name | NKD2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 451 | |
| Subcellular Localization | Cell membrane . Cytoplasm . Cytoplasmic vesicle . | |
| Protein Description | Cell autonomous antagonist of the canonical Wnt signaling pathway. May activate a second Wnt signaling pathway that controls planar cell polarity (By similarity). Required for processing of TGFA and for targeting of TGFA to the basolateral membrane of polarized epithelial cells.. | |
| Protein Sequence | MGKLQSKHAAAARKRRESPEGDSFVASAYASGRKGAEEAERRARDKQELPNGDPKEGPFREDQCPLQVALPAEKAEGREHPGQLLSADDGERAANREGPRGPGGQRLNIDALQCDVSVEEDDRQEWTFTLYDFDNCGKVTREDMSSLMHTIYEVVDASVNHSSGSSKTLRVKLTVSPEPSSKRKEGPPAGQDREPTRCRMEGELAEEPRVADRRLSAHVRRPSTDPQPCSERGPYCVDENTERRNHYLDLAGIENYTSRFGPGSPPVQAKQEPQGRASHLQARSRSQEPDTHAVHHRRSQVLVEHVVPASEPAARALDTQPRPKGPEKQFLKSPKGSGKPPGVPASSKSGKAFSYYLPAVLPPQAPQDGHHLPQPPPPPYGHKRYRQKGREGHSPLKAPHAQPATVEHEVVRDLPPTPAGEGYAVPVIQRHEHHHHHEHHHHHHHHHFHPS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Myristoylation | ------MGKLQSKHA ------CCHHHHHHH | 39.11 | 15064403 | |
| 2 | N-myristoyl glycine | ------MGKLQSKHA ------CCHHHHHHH | 39.11 | - | |
| 18 | Phosphorylation | AARKRRESPEGDSFV HHHHHHCCCCCCHHH | 26.83 | 23312004 | |
| 23 | Phosphorylation | RESPEGDSFVASAYA HCCCCCCHHHHHHHH | 32.26 | 23312004 | |
| 27 | Phosphorylation | EGDSFVASAYASGRK CCCHHHHHHHHHCCC | 19.26 | 25003641 | |
| 29 | Phosphorylation | DSFVASAYASGRKGA CHHHHHHHHHCCCCH | 9.98 | 27642862 | |
| 31 | Phosphorylation | FVASAYASGRKGAEE HHHHHHHHCCCCHHH | 26.84 | - | |
| 74 | Ubiquitination | QVALPAEKAEGREHP EEEEEHHHHCCCCCC | 54.57 | - | |
| 86 | Phosphorylation | EHPGQLLSADDGERA CCCCCEEECCCCCHH | 37.94 | 28555341 | |
| 117 | Phosphorylation | DALQCDVSVEEDDRQ EEEECCEEECCCCCC | 15.57 | 26471730 | |
| 127 | Phosphorylation | EDDRQEWTFTLYDFD CCCCCEEEEEEEECC | 13.14 | 29978859 | |
| 129 | Phosphorylation | DRQEWTFTLYDFDNC CCCEEEEEEEECCCC | 19.62 | 29978859 | |
| 131 | Phosphorylation | QEWTFTLYDFDNCGK CEEEEEEEECCCCCC | 16.11 | 29978859 | |
| 145 | Phosphorylation | KVTREDMSSLMHTIY CCCHHHHHHHHHHHH | 32.42 | 22210691 | |
| 146 | Phosphorylation | VTREDMSSLMHTIYE CCHHHHHHHHHHHHH | 24.07 | 22210691 | |
| 152 | Phosphorylation | SSLMHTIYEVVDASV HHHHHHHHHHHHHHC | 12.11 | 22210691 | |
| 174 | Phosphorylation | KTLRVKLTVSPEPSS CEEEEEEEECCCCCC | 17.14 | 30576142 | |
| 176 | Phosphorylation | LRVKLTVSPEPSSKR EEEEEEECCCCCCCC | 20.50 | 30576142 | |
| 180 | Phosphorylation | LTVSPEPSSKRKEGP EEECCCCCCCCCCCC | 46.99 | 28450419 | |
| 181 | Phosphorylation | TVSPEPSSKRKEGPP EECCCCCCCCCCCCC | 47.39 | 26074081 | |
| 216 | Phosphorylation | RVADRRLSAHVRRPS CHHCCCHHHHCCCCC | 17.95 | 27422710 | |
| 223 | Phosphorylation | SAHVRRPSTDPQPCS HHHCCCCCCCCCCCC | 43.56 | 28450419 | |
| 224 | Phosphorylation | AHVRRPSTDPQPCSE HHCCCCCCCCCCCCC | 55.15 | 30576142 | |
| 230 | Phosphorylation | STDPQPCSERGPYCV CCCCCCCCCCCCCCC | 36.69 | 23312004 | |
| 235 | Phosphorylation | PCSERGPYCVDENTE CCCCCCCCCCCCCCC | 14.13 | 23312004 | |
| 241 | Phosphorylation | PYCVDENTERRNHYL CCCCCCCCCCCCCCC | 28.90 | 23312004 | |
| 247 | Phosphorylation | NTERRNHYLDLAGIE CCCCCCCCCCHHCCC | 12.88 | 23312004 | |
| 256 | Phosphorylation | DLAGIENYTSRFGPG CHHCCCCCHHCCCCC | 8.03 | 25884760 | |
| 257 | Phosphorylation | LAGIENYTSRFGPGS HHCCCCCHHCCCCCC | 25.63 | 27642862 | |
| 264 | Phosphorylation | TSRFGPGSPPVQAKQ HHCCCCCCCCCCCCC | 29.21 | 27499020 | |
| 284 | Phosphorylation | ASHLQARSRSQEPDT HHHHHHHHHCCCCCC | 39.02 | 29449344 | |
| 286 | Phosphorylation | HLQARSRSQEPDTHA HHHHHHHCCCCCCHH | 39.89 | 30576142 | |
| 291 | Phosphorylation | SRSQEPDTHAVHHRR HHCCCCCCHHHCCCC | 23.58 | 23312004 | |
| 299 | Phosphorylation | HAVHHRRSQVLVEHV HHHCCCCHHEEEEEE | 25.29 | 21712546 | |
| 333 | Phosphorylation | PEKQFLKSPKGSGKP CHHHHCCCCCCCCCC | 33.71 | 24719451 | |
| 394 | Phosphorylation | QKGREGHSPLKAPHA HCCCCCCCCCCCCCC | 42.66 | 28122231 | |
| 405 | Phosphorylation | APHAQPATVEHEVVR CCCCCCCEEEEEEEC | 32.86 | 29214152 | |
| 423 | Phosphorylation | PTPAGEGYAVPVIQR CCCCCCCCEEEEEEC | 10.50 | 27642862 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NKD2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NKD2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RNF25_HUMAN | RNF25 | physical | 18757723 | |
| DVL1_HUMAN | DVL1 | physical | 20177058 | |
| CADH1_HUMAN | CDH1 | physical | 20177058 | |
| CAV1_HUMAN | CAV1 | physical | 20177058 | |
| ZN363_HUMAN | RCHY1 | physical | 21988832 | |
| VDR_HUMAN | VDR | physical | 21988832 | |
| 1433E_HUMAN | YWHAE | physical | 26186194 | |
| 1433Z_HUMAN | YWHAZ | physical | 26186194 | |
| ARMT1_HUMAN | C6orf211 | physical | 26186194 | |
| PLSI_HUMAN | PLS1 | physical | 26186194 | |
| UB2D2_HUMAN | UBE2D2 | physical | 26186194 | |
| UB2E3_HUMAN | UBE2E3 | physical | 26186194 | |
| 1433Z_HUMAN | YWHAZ | physical | 28514442 | |
| UB2D2_HUMAN | UBE2D2 | physical | 28514442 | |
| 1433G_HUMAN | YWHAG | physical | 28514442 | |
| 1433E_HUMAN | YWHAE | physical | 28514442 | |
| 1433B_HUMAN | YWHAB | physical | 28514442 | |
| ARMT1_HUMAN | C6orf211 | physical | 28514442 | |
| PLSI_HUMAN | PLS1 | physical | 28514442 | |
| PMVK_HUMAN | PMVK | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Myristoylation | |
| Reference | PubMed |
| "Myristoylated Naked2 escorts transforming growth factor alpha to thebasolateral plasma membrane of polarized epithelial cells."; Li C., Franklin J.L., Graves-Deal R., Jerome W.G., Cao Z.,Coffey R.J.; Proc. Natl. Acad. Sci. U.S.A. 101:5571-5576(2004). Cited for: FUNCTION, INTERACTION WITH TGFA, SUBCELLULAR LOCATION, MYRISTOYLATION,AND MUTAGENESIS OF GLY-2. | |